Weiyan Zhang Selected Research

Weiyan Zhang Research Topics

Disease

3	Neoplasms (Cancer) 03/2024 - 11/2014
3	Tuberculosis (Tuberculoses) 01/2024 - 01/2022
2	Infections 01/2024 - 01/2023
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023 - 01/2021
2	Pneumonia (Pneumonitis) 01/2022 - 01/2022
1	Testicular Neoplasms (Testicular Cancer) 03/2024
1	Choroid Plexus Papilloma 01/2023
1	Extensively Drug-Resistant Tuberculosis 01/2023
1	Virus Diseases (Viral Diseases) 06/2022
1	Inflammation (Inflammations) 01/2022
1	Ischemic Stroke 01/2021
1	Stroke (Strokes) 01/2021
1	Thromboinflammation 01/2021
1	Shock 08/2020
1	Poliomyelitis (Polio) 01/2020
1	Insulin Resistance 03/2019
1	Non-alcoholic Fatty Liver Disease 03/2019
1	Fatty Liver 03/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Neutropenia 01/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Ischemia 10/2015
1	Adenocarcinoma of Lung 11/2014
1	Hyperhomocysteinemia 10/2014
1	Congenital Heart Defects (Congenital Heart Defect) 10/2014
1	Pulmonary Arterial Hypertension 01/2014
1	Periodontitis 09/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2012
1	Chronic Hepatitis B 09/2012
1	Liver Diseases (Liver Disease) 09/2012
1	Hepatitis B 09/2012

Drug/Important Bio-Agent (IBA)

3	bedaquiline (R207910)IBA 01/2024 - 01/2022
2	Clofazimine (Lamprene)FDA Link 01/2022 - 01/2021
1	Peptides (Polypeptides)IBA 03/2024
1	birinapantIBA 03/2024
1	Inhibitor of Apoptosis ProteinsIBA 03/2024
1	Immune Checkpoint InhibitorsIBA 03/2024
1	AntigensIBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	sudapyridineIBA 01/2024
1	macozinoneIBA 01/2023
1	Linezolid (Zyvox)FDA Link 01/2023
1	pretomanidIBA 01/2023
1	Oxazolidinones (2 Oxazolidone)IBA 01/2023
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 06/2022
1	CytokinesIBA 06/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Pyrazinamide FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 01/2022
1	growth arrest specific transcript 5IBA 01/2022
1	LipidsIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Polyethylene (Polythene)IBA 08/2020
1	CarbonIBA 08/2020
1	PolyethylenesIBA 08/2020
1	VaccinesIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 03/2019
1	nasIBA 03/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2019
1	Sirtuin 1IBA 03/2019
1	Transcription Factors (Transcription Factor)IBA 03/2019
1	Triglycerides (Triacylglycerol)IBA 03/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2017
1	Brentuximab VedotinIBA 01/2017
1	Maytansine (Maitansine)IBA 01/2017
1	Nicorandil (SG 75)IBA 10/2015
1	Calcitriol (Calcijex)FDA LinkGeneric 11/2014
1	Cisplatin (Platino)FDA LinkGeneric 11/2014
1	Sincalide FDA Link 11/2014
1	Vitamin D FDA LinkGeneric 11/2014
1	methionine synthase reductaseIBA 10/2014
1	Gap Junction alpha-5 ProteinIBA 01/2014
1	Neuraminidase (Sialidase)IBA 09/2013
1	AdiponectinIBA 09/2012

Therapy/Procedure

2	Therapeutics 03/2024 - 06/2022
1	Endoscopes 01/2023
1	Immunotherapy 06/2022
1	Thrombectomy 01/2021
1	Neoadjuvant Therapy 01/2019